Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents
Authors:
- Christopher K. ArnattCAChristopher K. Arnatt
- Kendra M. HaneyKHKendra M. Haney
- Harrison C. FangHFHarrison C. Fang
- John E. BajacanJBJohn E. Bajacan
- Amanda C. RichardsonARAmanda C. Richardson
- Joy L. WareJWJoy L. Ware
- Yan ZhangYZYan Zhang
- 1 September 2012
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 55, 395-408
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Regio- and Stereoselective Syntheses of the Natural Product CCR5 Antagonist Anibamine and its Three Olefin IsomersThe Journal of Organic Chemistry, 2011
- Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agentsBioorganic & Medicinal Chemistry Letters, 2010
- Catalytic Chain-Breaking Pyridinol AntioxidantsThe Journal of Organic Chemistry, 2010
- Comparative Docking Study of Anibamine as the First Natural Product CCR5 Antagonist in CCR5 Homology ModelsJournal of Chemical Information and Modeling, 2009
- Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140)Antimicrobial Agents and Chemotherapy, 2008
- Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generationClinical and Experimental Immunology, 2006
- Inflammation and cancerNature, 2002
- Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial ChemistryJournal of Chemical Information and Computer Sciences, 2002
- Chemotactic factors, passive invasion and metastasis of cancer cellsImmunology Today, 1992
- The origin and function of tumor-associated macrophagesImmunology Today, 1992